ArchiveSCV
the-signal.com. The Santa Clarita Valley Signal. Back to the collection.

· signalscv.com, Wayback capture

MannKind receives $50 million

MannKind Corporation of Santa Clarita announced Thursday that it earned a milestone payment of $50 million in payments from its licensing agreement with Sanofi.

Previously, MannKind received a $150 million upfront payment when the agreement was made for Sanofi to take the biomedical device company’s diabetes inhaler treatment Afrezza to market.

MannKind is also eligible to earn up to $725 million in further development, regulatory and sales milestones, and is also eligible to receive a share of profits on sales of Afrezza.

← Back to 2015

About this record

How it was held, read and classified

Record details

Morris ID
131600
System
Morris section CMS (/section/…/article/… and /archives/…)
Reading copy
signalscv.com
Chosen by: only copy held. On this copy: words 82 (e-mail addresses counted as one token); reader comments 0 (counted, not reproduced here); images 0.
Extracted by
section_cms:articlebody_span
signal-extract/0.15 (2026-11-16)

Other copies

Held
None. The holding has this article from one host only.

How it was classified

Label
clearly-local
Judgment
A machine’s (recorded as machine), kept as one so it can be revisited.
Classifier
signal-localclass/0.7 (2026-11-12)
Local signals
  • url:section_24_local
  • byline:staff_marker [Signal Staff]
  • text:valley_names [1 distinct/1 mentions: Santa Clarita]
National signals
none fired
Scores
local 7, national 0